Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hardwin Mead

Showing results (11-20 of 40) with videos related to

Pageof 4
Sort By:
Journal of Cardiovascular Electrophysiology|September 30, 2011
The use of dabigatran immediately after atrial fibrillation ablationRoger A Winkle, R Hardwin Mead, Gregory Engel, et al.
Journal of Interventional Cardiac Electrophysiology : an International Journal of Arrhythmias and Pacing|February 28, 2012
Trends in atrial fibrillation ablation: have we maximized the current paradigms?Roger A Winkle, R Hardwin Mead, Gregory Engel, et al.
Heart Rhythm|April 1, 2014
Atrial fibrillation ablation using open-irrigated tip radiofrequency: experience with intraprocedural activated clotting times ≤210 secondsRoger A Winkle, R Hardwin Mead, Gregory Engel, et al.
Journal of Interventional Cardiac Electrophysiology : an International Journal of Arrhythmias and Pacing|October 9, 2013
Discontinuing anticoagulation following successful atrial fibrillation ablation in patients with prior strokesRoger A Winkle, R Hardwin Mead, Gregory Engel, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|August 14, 2014
Peri-procedural interrupted oral anticoagulation for atrial fibrillation ablation: comparison of aspirin, warfarin, dabigatran, and rivaroxabanRoger A Winkle, R Hardwin Mead, Gregory Engel, et al.
The American Journal of Cardiology|June 5, 2012
Atrial arrhythmia burden on long-term monitoring in asymptomatic patients late after atrial fibrillation ablationRoger A Winkle, R Hardwin Mead, Gregory Engel, et al.
Journal of Interventional Cardiac Electrophysiology : an International Journal of Arrhythmias and Pacing|March 14, 2013
Physician-controlled costs: the choice of equipment used for atrial fibrillation ablationRoger A Winkle, R Hardwin Mead, Gregory Engel, et al.
Journal of the American College of Cardiology|September 15, 2012
Safety of dabigatran versus warfarin for periprocedural anticoagulation in patients undergoing ablation for atrial fibrillationRoger A Winkle, R Hardwin Mead, Gregory Engel, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|September 17, 2013
Comparison of CHADS2 and CHA2DS2-VASC anticoagulation recommendations: evaluation in a cohort of atrial fibrillation ablation patientsRoger A Winkle, R Hardwin Mead, Gregory Engel, et al.
Journal of Clinical Medicine|July 9, 2022
Mobile Cardiac Acoustic Monitoring System to Evaluate Left Ventricular Systolic Function in Pacemaker PatientsJingjuan Huang, Weiwei Zhang, Changqing Pan, et al.
Pageof 4

Showing results (11-20 of 40) with videos related to

Sort By:
Pageof 4
Journal of Cardiovascular Electrophysiology|September 30, 2011
The use of dabigatran immediately after atrial fibrillation ablationRoger A Winkle, R Hardwin Mead, Gregory Engel, et al.
Journal of Interventional Cardiac Electrophysiology : an International Journal of Arrhythmias and Pacing|February 28, 2012
Trends in atrial fibrillation ablation: have we maximized the current paradigms?Roger A Winkle, R Hardwin Mead, Gregory Engel, et al.
Heart Rhythm|April 1, 2014
Atrial fibrillation ablation using open-irrigated tip radiofrequency: experience with intraprocedural activated clotting times ≤210 secondsRoger A Winkle, R Hardwin Mead, Gregory Engel, et al.
Journal of Interventional Cardiac Electrophysiology : an International Journal of Arrhythmias and Pacing|October 9, 2013
Discontinuing anticoagulation following successful atrial fibrillation ablation in patients with prior strokesRoger A Winkle, R Hardwin Mead, Gregory Engel, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|August 14, 2014
Peri-procedural interrupted oral anticoagulation for atrial fibrillation ablation: comparison of aspirin, warfarin, dabigatran, and rivaroxabanRoger A Winkle, R Hardwin Mead, Gregory Engel, et al.
The American Journal of Cardiology|June 5, 2012
Atrial arrhythmia burden on long-term monitoring in asymptomatic patients late after atrial fibrillation ablationRoger A Winkle, R Hardwin Mead, Gregory Engel, et al.
Journal of Interventional Cardiac Electrophysiology : an International Journal of Arrhythmias and Pacing|March 14, 2013
Physician-controlled costs: the choice of equipment used for atrial fibrillation ablationRoger A Winkle, R Hardwin Mead, Gregory Engel, et al.
Journal of the American College of Cardiology|September 15, 2012
Safety of dabigatran versus warfarin for periprocedural anticoagulation in patients undergoing ablation for atrial fibrillationRoger A Winkle, R Hardwin Mead, Gregory Engel, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|September 17, 2013
Comparison of CHADS2 and CHA2DS2-VASC anticoagulation recommendations: evaluation in a cohort of atrial fibrillation ablation patientsRoger A Winkle, R Hardwin Mead, Gregory Engel, et al.
Journal of Clinical Medicine|July 9, 2022
Mobile Cardiac Acoustic Monitoring System to Evaluate Left Ventricular Systolic Function in Pacemaker PatientsJingjuan Huang, Weiwei Zhang, Changqing Pan, et al.
Pageof 4